Results 161 to 170 of about 15,719 (229)

Assessing the Impact of TLR4 rs4986790 Polymorphism on Bacterial Meningitis Risk: A Systematic Review and Meta-Analysis. [PDF]

Ann Indian Acad Neurol
Sekar PKC, Veerabathiran R.
europepmc   +1 more source

Management and prevention of Neisseria meningitidis and Neisseria gonorrhoeae infections in the context of evolving antimicrobial resistance trends. [PDF]

Eur J Clin Microbiol Infect Dis
Marshall HS, Molina JM, Berlaimont V, Mulgirigama A, Sohn WY, Berçot B, Bobde S.   +6 more
europepmc   +1 more source

Isolation of human monoclonal antibodies from 4CMenB vaccinees reveals PorB and LOS as the main OMV components inducing cross-strain protection. [PDF]

Front Immunol
Vezzani G, Viviani V, Audagnotto M, Rossi A, Cinelli P, Pacchiani N, Limongi C, Santini L, Giusti F, Tomei S, Torricelli G, Faenzi E, Sammicheli C, Tavarini S, Efron A, Biolchi A, Finco O, Delany I, Frigimelica E.   +18 more
europepmc   +1 more source

Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany. [PDF]

Infect Dis Ther
Gruhn S, Batram M, Wick M, Langevin E, Scholz S, Greiner W, Damm O.   +6 more
europepmc   +1 more source

Development and evaluation of rapid antigenic tests for the diagnosis of meningococcal and pneumococcal infections

, 2019
Cyrille Hedi Haddar
openalex   +1 more source

A Bioluminescence-Based Serum Bactericidal Assay to Detect Bactericidal Antibodies Against <i>Neisseria meningitidis</i> in Human Sera. [PDF]

Microorganisms
Fantoni G, Deghmane AE, Caron F, Taha MK.   +3 more
europepmc   +1 more source

A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix^® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age. [PDF]

Infect Dis Ther
Koski S, Martinon-Torres F, Rämet M, Zolotas L, Newton R, Maansson R, Cutler M, Peyrani P, Findlow J, Balmer P, Jodar L, Gruber WC, Anderson AS, Beeslaar J.   +13 more
europepmc   +1 more source

Human Factor H and anti-Neisserial surface protein A (NspA) antibodies compete for overlapping binding sites on meningococcal NspA. [PDF]

Infect Immun
Raghunathan D, Lim SS, Moe GR, Beernink PT.   +3 more
europepmc   +1 more source

Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine. [PDF]

mSphere
Borrow R, Tomasi Cont L, Toneatto D, Bambini S, Bobde S, Sohn W-Y, Biolchi A, Masignani V, Beernink PT, Lattanzi M.   +9 more
europepmc   +1 more source